Transposable elements shape olaparib response according to BRCA1 status in triple-negative breast cancer
Daniela Moreira Mombach, Carlos Mendez‐Dorantes, Rafael L. V. Mercuri, Phillip Schofield, Suelen Cristina Soares Baal, Maria Augusta Poersch, Kathleen H. Burns, Jaqueline Carvalho de Oliveira, Élgion L. S. Loreto, Pedro A. F. Galante
This paper shows that olaparib treatment increases transposable element activity in BRCA1-deficient triple-negative breast cancer cells, leading to genomic instability and immune responses.
bioRxiv · Jul 16, 2026 · PreprintCancer Biology